Nan Fung Group Holdings as of March 31, 2024
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 45 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Illumina (ILMN) | 15.2 | $16M | 119k | 137.32 | |
| Harmony Biosciences Hldgs In (HRMY) | 11.5 | $12M | 369k | 33.58 | |
| Alpine Immune Sciences | 9.7 | $11M | 264k | 39.64 | |
| Oculis Holding Ordinary Shares (OCS) | 4.9 | $5.3M | 436k | 12.05 | |
| D Fluidigm Corp Del (LAB) | 4.7 | $5.1M | 1.9M | 2.71 | |
| Exscientia Ads (EXAI) | 4.6 | $4.9M | 860k | 5.72 | |
| Xenon Pharmaceuticals (XENE) | 4.3 | $4.6M | 107k | 43.05 | |
| Geron Corporation (GERN) | 4.1 | $4.4M | 1.3M | 3.30 | |
| Incyte Corporation (INCY) | 3.9 | $4.2M | 74k | 56.97 | |
| Merus N V (MRUS) | 3.7 | $4.0M | 90k | 45.03 | |
| Beigene Sponsored Adr (BGNE) | 3.3 | $3.6M | 23k | 156.39 | |
| Kalvista Pharmaceuticals (KALV) | 2.4 | $2.6M | 219k | 11.86 | |
| Longboard Pharmaceuticals In (LBPH) | 2.4 | $2.6M | 118k | 21.60 | |
| Mirum Pharmaceuticals (MIRM) | 2.2 | $2.4M | 96k | 25.12 | |
| Rhythm Pharmaceuticals (RYTM) | 2.0 | $2.1M | 49k | 43.33 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.9 | $2.1M | 14k | 151.17 | |
| ACADIA Pharmaceuticals (ACAD) | 1.8 | $1.9M | 103k | 18.49 | |
| Replimune Group (REPL) | 1.6 | $1.7M | 205k | 8.17 | |
| Bolt Biotherapeutics (BOLT) | 1.5 | $1.6M | 1.2M | 1.40 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 1.4 | $1.5M | 494k | 3.11 | |
| Exelixis (EXEL) | 1.4 | $1.5M | 64k | 23.73 | |
| Madrigal Pharmaceuticals (MDGL) | 1.4 | $1.5M | 5.7k | 267.04 | |
| Aerovate Therapeutics (AVTE) | 1.3 | $1.4M | 48k | 29.57 | |
| Pacific Biosciences of California (PACB) | 1.0 | $1.0M | 275k | 3.75 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $945k | 11k | 87.34 | |
| Neumora Therapeutics (NMRA) | 0.8 | $871k | 63k | 13.75 | |
| Cabaletta Bio (CABA) | 0.7 | $804k | 47k | 17.06 | |
| Entrada Therapeutics (TRDA) | 0.6 | $696k | 49k | 14.17 | |
| Biomea Fusion (BMEA) | 0.6 | $598k | 40k | 14.95 | |
| Athira Pharma (ATHA) | 0.5 | $493k | 180k | 2.74 | |
| Tourmaline Bio (TRML) | 0.4 | $481k | 21k | 22.90 | |
| Alx Oncology Hldgs (ALXO) | 0.4 | $468k | 42k | 11.15 | |
| Immunocore Hldgs Ads (IMCR) | 0.4 | $439k | 6.8k | 65.00 | |
| Kymera Therapeutics (KYMR) | 0.4 | $437k | 11k | 40.20 | |
| Springworks Therapeutics (SWTX) | 0.3 | $367k | 7.5k | 49.22 | |
| Roivant Sciences SHS (ROIV) | 0.3 | $342k | 33k | 10.54 | |
| Dbv Technologies S A Sponsored Adr | 0.3 | $278k | 371k | 0.75 | |
| Revolution Medicines (RVMD) | 0.2 | $235k | 7.3k | 32.23 | |
| Abcellera Biologics (ABCL) | 0.2 | $231k | 51k | 4.53 | |
| Affimed N V Ordinary Shs New (AFMD) | 0.2 | $197k | 37k | 5.30 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $187k | 37k | 5.08 | |
| Kodiak Sciences (KOD) | 0.2 | $168k | 32k | 5.26 | |
| Immatics SHS (IMTX) | 0.2 | $165k | 16k | 10.51 | |
| Fibrogen (FGEN) | 0.1 | $146k | 62k | 2.35 | |
| Galera Therapeutics (GRTX) | 0.1 | $86k | 613k | 0.14 |
